Precise protein design offers hope for damaged hearts and kidneys

FHS
June 18, 2024
5:31 am

Using computer-designed proteins, researchers have now shown they are able to direct human stem cells to form new blood vessels in the lab. This milestone in regenerative medicine offers new hope for repairing damaged hearts, kidneys, and other organs.

JPM 2024: FogPharma’s new CEO, Mathai Mammen, unveils ‘contrarian’ plan in oncology

SAN FRANCISCO — Six months into his tenure as CEO of cancer startup FogPharma, Mathai Mammen is taking the stage at the Westin St. Francis

January 9, 2024

Developing high-potent APIs: The necessary steps to follow – Pharmaceutical Technology

Rigorous measures need to be in place to protect clinical staff from toxic HPAPIs. Image credit: Gorodenkoff The demand for high-potency active pharmaceutical ingredients (HPAPIs)

August 6, 2024

FDA issues second CRL to Supernus for Parkinson’s drug-device combo

It seems Supernus Pharmaceuticals will need a super effort to get its Parkinson’s treatment approved. The FDA rejected the company’s therapy for a second time

April 9, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.